Day: August 27, 2025

Björn Lindberg, Senior Lecturer in Mathematics with the modified shopping cart.Image, from video produced by LNU IT JLT Mobile Computers, in close collaboration with Linnaeus University, has developed an innovative AI-powered solution to improve safety in industrial environments.  Växjö, Sweden, 27 August 2025 * * * JLT Mobile Computers, a leading developer of rugged computing solutions for demanding environments, has partnered on a project with Linnaeus University in Sweden to develop Screen Blanking, an innovative AI-driven safety application that reduces driver distraction and helps companies comply with evolving global regulations. The Screen Blanking solution uses Artificial Intelligence (AI) and Machine Learning (ML) to automatically blank the display of vehicle-mounted computers when the vehicle is moving, restoring it as soon...

GXO partners with B&Q to transition their entire logistics fleet to alternative fuels, now operating the second largest LNG fleet in the UK B&Q piloting GXO’s proprietary AI-powered transport optimization platform, driving estimated savings of 240,000 kilometres and 150 tonnes of CO₂ annually LONDON, UK, Aug. 27, 2025 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, and B&Q, the UK’s leading home improvement and garden living retailer, are making strong progress toward their shared goal of achieving net-zero carbon emissions across B&Q’s logistics operations by 2040. Since the partnership began in 2015, GXO has managed B&Q’s retail transport network, including national and regional distribution centres, Store to Home final mile services, returns...

                                        Regulated information August 27, 2025 – 7:45 a.m. CET        The Agfa-Gevaert Group in Q2 2025: strong HealthCare IT performance, stable Digital Print & Chemicals performance – further decline in medical filmGroup performance:Strong HealthCare IT performance and stable Digital Print & Chemicals performance not sufficiently offsetting the continued fast decline in medical film Adjusted EBITDA decreased to 13 million euro – effects of measures to tackle the decline in medical film will start to kick in in the second half of 2025 Net profit of 30 million euro with a strong positive impact from the final award in the AgfaPhoto arbitration Signing of a new 3-year revolving credit facility of 180 million euroHealthCare IT: strong Q2 and continued successful transition to cloud,...

The leadership of Civinity, one of the largest groups in the Baltics providing building maintenance services and developing engineering and technology solutions, is undergoing a change. With CEO Virgeda Jackaitė going on maternity leave after more than two years at the helm, Tomas Staškūnas has been appointed Acting Chief Executive Officer. Virgeda Jackaitė has led Civinity since May 29, 2023. She is temporarily stepping down from her position as CEO to take maternity leave. As of August 27, the role of Chief Executive Officer is assumed on an interim basis by Tomas Staškūnas, who until now has served as the Group’s Chief Financial Officer. Tomas Staškūnas has more than 20 years of experience in finance, where he has held various leadership positions. For over twelve years, he headed the finance department of the Novaturas Group. Staškūnas...

IDEX Biometrics ASA’s first half 2025 report is attached to this notice. Recent highlights:Operating expenses excluding Cost of materials and Depreciation in the first six months of 2025 amounted to $5.2 million (excluding restructuring cost) compared to $10.7 million for the same period in 2024, resulting in a cost reduction of 52%, year-over-year At the end of the second quarter of 2025 the Company had 30 full-time equivalent staff members, a reduction of 10 full-time equivalents compared to previous quarter, and down from 59 on June 30, 2024. Resulted in a cost reduction in compensation and benefits of $1.9 million, 73%, compared to previous quarter, and a cost reduction of $4.1 million, 72%, year-over-year. Heights convertible bond renegotiated and amendedOutstanding principal reduced from approx. NOK66.6 million to approx....

Vivoryon Therapeutics N.V. to Report H1 2025 Financial Results and Operational Progress on September 4, 2025 Halle (Saale) / Munich, Germany, August 27, 2025 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company developing small molecule medicines for inflammatory and fibrotic disorders, with a primary focus on kidney diseases, today announced that it will publish its half year financial results for the period ended June 30, 2025 and provide a corporate update on Thursday, September 4, 2025. The Company will host a conference call and webcast open to the public. The report will be available for download on the Company’s website (https://www.vivoryon.com/financial-information/). Conference call detailsDate: September 4, 2025Time: 3:00 pm CEST / 9:00 am EDT The conference call...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – August 27, 2025Idorsia Ltd (SIX: IDIA) settled the repurchase offer for its outstanding CHF 204* million convertible bonds maturing in 2025 (CB 2025; ISIN CH0426820350) and CHF 600 million convertible bonds maturing in 2028 (CB 2028; ISIN CH1128004079) launched on June 25, 2025 (the Repurchase Offer). Bondholders accepted the Repurchase Offer for the CB 2025 with an aggregate nominal value of CHF 187,476,000, corresponding to 91.90% of the total issued nominal value of the CB 2025, and for the CB 2028 with an aggregate nominal value of CHF 567,200,000, corresponding to 94.53% of the total issued nominal value of the CB 2028. The documentation in relation to the Repurchase Offer (the Repurchase Offer Documentation) can be found at the following link: www.idorsia.com/exchange-offer. For...